Cordasco Financial Network Arca Biopharma, Inc. Transaction History

Cordasco Financial Network

  • $138 Million
  • Q2 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 12, 2021
SELL
$3.48 - $5.3 $69 - $106
-20 Closed
0 $0
Q1 2020

Apr 24, 2020
BUY
$2.32 - $6.42 $46 - $128
20 New
20 $0

Others Institutions Holding ABIO

# of Institutions
2
Shares Held
280K
Call Options Held
0
Put Options Held
0
View Full List

About ARCA biopharma, Inc.

ABIO Quotes by TradingView
  • Ticker ABIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,410,100
  • Description
  • ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...
More about ABIO
Track This Portfolio

Track Cordasco Financial Network Portfolio

Follow Cordasco Financial Network and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cordasco Financial Network, based on Form 13F filings with the SEC.

News

Stay updated on Cordasco Financial Network with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email